Effects of methylphenidate on children with attention deficit hyperactivity disorder: a study using clinical and multimodal approaches including go/no-go task and functional near-infrared spectroscopy

CONCLUSION: Our findings suggest that activation in the right mPFC is a viable objective neurofunctional biomarker for monitoring MPH treatment response using fNIRS. Concurrently, a multimodal assessment strategy integrating clinical evaluations, neuropsychological testing (go/no-go task), and fNIRS holds significant promise as a robust method for objectively determining the therapeutic efficacy of MPH in pediatric ADHD.

via https://pubmed.ncbi.nlm.nih.gov/41446796/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20260109011006&v=2.18.0.post22+67771e2